FDA Moves on Peptides: What Compounding Pharmacies Need to Know August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines FDA's confusing warning letters The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 18: peptides part II Carol Magalhes Isaacs Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022 Journal of Pharmaceutical Innovation Springer Nature Link